Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa

Wei Chang, Gabriel Chamie, Daniel Mwai, Tamara D Clark, Harsha Thirumurthy, Edwin D Charlebois, Maya Petersen, Jane Kabami, Emmanuel Ssemmondo, Kevin Kadede, Dalsone Kwarisiima, Norton Sang, Elizabeth A Bukusi, Craig R Cohen, Moses Kamya, Diane V Havlir, James G Kahn, Wei Chang, Gabriel Chamie, Daniel Mwai, Tamara D Clark, Harsha Thirumurthy, Edwin D Charlebois, Maya Petersen, Jane Kabami, Emmanuel Ssemmondo, Kevin Kadede, Dalsone Kwarisiima, Norton Sang, Elizabeth A Bukusi, Craig R Cohen, Moses Kamya, Diane V Havlir, James G Kahn

Abstract

Background: In 2013-2014, we achieved 89% adult HIV testing coverage using a hybrid testing approach in 32 communities in Uganda and Kenya (SEARCH: NCT01864603). To inform scalability, we sought to determine: (1) overall cost and efficiency of this approach; and (2) costs associated with point-of-care (POC) CD4 testing, multidisease services, and community mobilization.

Methods: We applied microcosting methods to estimate costs of population-wide HIV testing in 12 SEARCH trial communities. Main intervention components of the hybrid approach are census, multidisease community health campaigns (CHC), and home-based testing for CHC nonattendees. POC CD4 tests were provided for all HIV-infected participants. Data were extracted from expenditure records, activity registers, staff interviews, and time and motion logs.

Results: The mean cost per adult tested for HIV was $20.5 (range: $17.1-$32.1) (2014 US$), including a POC CD4 test at $16 per HIV+ person identified. Cost per adult tested for HIV was $13.8 at CHC vs. $31.7 by home-based testing. The cost per HIV+ adult identified was $231 ($87-$1245), with variability due mainly to HIV prevalence among persons tested (ie, HIV positivity rate). The marginal costs of multidisease testing at CHCs were $1.16/person for hypertension and diabetes, and $0.90 for malaria. Community mobilization constituted 15.3% of total costs.

Conclusions: The hybrid testing approach achieved very high HIV testing coverage, with POC CD4, at costs similar to previously reported mobile, home-based, or venue-based HIV testing approaches in sub-Saharan Africa. By leveraging HIV infrastructure, multidisease services were offered at low marginal costs.

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Cost breakdown by input category for each intervention component in the hybrid mobile multi-disease testing approach among 12 communities in Uganda and Kenya
Figure 2
Figure 2
Comparison of cost per person tested and HIV testing coverage using community-based HIV testing and counseling strategies in sub-Saharan Africa (excluding South Africa). See discussion in text.
Figure 3
Figure 3
HIV positivity rate (i.e. HIV prevalence among persons tested) and cost per person testing HIV-positive using different community-based HIV testing strategies in sub-Saharan Africa

Source: PubMed

3
Subskrybuj